These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1991438)

  • 1. Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients.
    Mooradian AD; Reed RL; Meredith KE; Scuderi P
    Diabetes Care; 1991 Jan; 14(1):63-5. PubMed ID: 1991438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.
    Sun KH; Yu CL; Tang SJ; Sun GH
    Immunology; 2000 Mar; 99(3):352-60. PubMed ID: 10712664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA.
    Horwitz DA; Wang H; Gray JD
    Lupus; 1994 Oct; 3(5):423-8. PubMed ID: 7841998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines in sera from insulin-dependent diabetic patients at diagnosis.
    Cavallo MG; Pozzilli P; Bird C; Wadhwa M; Meager A; Visalli N; Gearing AJ; Andreani D; Thorpe R
    Clin Exp Immunol; 1991 Nov; 86(2):256-9. PubMed ID: 1934594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
    Desfaits AC; Serri O; Renier G
    Diabetes Care; 1998 Apr; 21(4):487-93. PubMed ID: 9571329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) in tracheal aspirates of newborns with pneumonia.
    Buck C; Gallati H; Pohlandt F; Bartmann P
    Infection; 1994; 22(4):238-41. PubMed ID: 8002082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble immunologic products in scleroderma sera.
    Kahaleh MB
    Clin Immunol Immunopathol; 1991 Jan; 58(1):139-44. PubMed ID: 1898505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice.
    Seino H; Satoh J; Shintani S; Takahashi K; Zhu XP; Masuda T; Nobunaga T; Saito M; Terano Y; Toyota T
    Clin Exp Immunol; 1991 Dec; 86(3):413-8. PubMed ID: 1747949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model.
    Doxey DL; Cutler CW; Iacopino AM
    J Periodontol; 1998 Feb; 69(2):113-9. PubMed ID: 9526909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment].
    Blay JY; Négrier S; Combaret V; Merrouche Y; Mercatello A; Moskovtchenko JF; Philip T; Favrot M
    Bull Cancer; 1992; 79(1):55-65. PubMed ID: 1520953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
    Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
    Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.